Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

choriocarcinoma of the central nervous system - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

choriocarcinoma of the central nervous system

MONDO:0016740

Also known as:central nervous system choriocarcinomacentral nervous system choriocarcinoma (disease)choriocarcinoma of CNS

Overview

A malignant germ cell tumor of the central nervous system characterized by extra-embryonic differentiation along trophoblastic lines. The diagnosis requires the identification of cytotrophoblastic elements, as well as syncytiotrophoblastic giant cells. (WHO)

ResearchLimited published research (9 articles)

Diagnosis

Biomarker and diagnostic research for choriocarcinoma of the central nervous system has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

No clinical trials have been registered for choriocarcinoma of the central nervous system.

12 publications have been identified in PubMed for choriocarcinoma of the central nervous system. Kisho has analyzed 9 by research type. Research spans Review / Meta-Analysis (33%), Diagnostic / Biomarker (22%), and Case Report / Case Series (22%).

Recent Publications

Janssen FW (2026). [PMID: 41998312](https://pubmed.ncbi.nlm.nih.gov/41998312/). *Commun Med (Lond)*. [Diagnostic / Biomarker]
Faure Conter C (2026). [PMID: 42115464](https://pubmed.ncbi.nlm.nih.gov/42115464/). *Adv Tech Stand Neurosurg*. [Review / Meta-Analysis]
Wang YF (2025). [PMID: 38821737](https://pubmed.ncbi.nlm.nih.gov/38821737/). *J Formos Med Assoc*. [Diagnostic / Biomarker]
Takami H (2025). [PMID: 41198340](https://pubmed.ncbi.nlm.nih.gov/41198340/). *Adv Cancer Res*. [Review / Meta-Analysis]
Bouille F (2025). [PMID: 41272818](https://pubmed.ncbi.nlm.nih.gov/41272818/). *Acta Neuropathol Commun*. [Case Report / Case Series]

Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 10:57 AM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:252015

GARD

Genetic and Rare Diseases Info Center

GARD:20734

Questions for Your Care Team

→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

choriocarcinoma of the central nervous system

Overview

Diagnosis

Research Landscape

Recent Publications

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team